TransCode Therapeutics Inc. Gains 42.55%
Wed, Feb 15, 2023 at 07:13 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $0.67, representing a gain of 42.6%. On Wed, Feb 15, 2023, RNAZ:NASDAQ touched a New 2-Week High of $0.67. The stock appeared on our News Catalysts scanner on Tue, Jan 31, 2023 at 05:34 PM in the 'BIOTECH' category. From Wed, Feb 01, 2023, the stock recorded 10.00% Up Days and 9.09% Green Days
The stock spiked on Wed, Feb 15, 2023 at $0.9 with a volume of 40M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Tenon Medical Inc. (TNON:NASDAQ), 120.2%
- Titan Medical Inc. (TMDI:NASDAQ), 82.16%
- Sera Prognostics Inc. (SERA:NASDAQ), 74.62%
- Iris Energy Limited (IREN:NASDAQ), 66.99%
- Redwire Corporation (RDW:NYSE), 48.82%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 42.55%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 33.85%
- Digital Ally, Inc. (DGLY:NASDAQ), 33.33%
- The Trade Desk, Inc. (TTD:NASDAQ), 32.81%
- QuantumScape Corporation Class A (QS:NYSE), 32.29%